Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124812914 | 12481291 | 4 | F | 20150112 | 20160810 | 20160620 | 20160815 | EXP | US-ASTELLAS-2016US022489 | ASTELLAS | 14.72 | YR | M | Y | 0.00000 | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124812914 | 12481291 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Topical | 0.1 %, TWICE DAILY | U | 50777 | .1 | PCT | OINTMENT | BID | |||||
| 124812914 | 12481291 | 2 | C | DESONIDE. | DESONIDE | 1 | Topical | 0.05 %, TWICE DAILY | U | 0 | .05 | PCT | FORMULATION UNKNOWN | BID | |||||
| 124812914 | 12481291 | 3 | C | EPIPEN | EPINEPHRINE | 1 | Intramuscular | U | 0 | .3 | MG | FORMULATION UNKNOWN | |||||||
| 124812914 | 12481291 | 4 | C | CELECOXIB. | CELECOXIB | 1 | Oral | U | 0 | 200 | MG | TABLET | BID | ||||||
| 124812914 | 12481291 | 5 | C | ALCLOMETASONE | ALCLOMETASONE | 1 | Topical | 0.05 %, TWICE DAILY | U | 0 | .05 | PCT | FORMULATION UNKNOWN | BID | |||||
| 124812914 | 12481291 | 6 | C | ETANERCEPT | ETANERCEPT | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | INJECTION | ||||||||
| 124812914 | 12481291 | 7 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Topical | U | 0 | 2.5 | PCT | CREAM | BID | ||||||
| 124812914 | 12481291 | 8 | C | TRIAMCINOLONE | TRIAMCINOLONE | 1 | Topical | 0.1 %, TWICE DAILY | U | 0 | .1 | PCT | OINTMENT | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124812914 | 12481291 | 1 | Dermatitis atopic |
| 124812914 | 12481291 | 2 | Dermatitis atopic |
| 124812914 | 12481291 | 3 | Anaphylactic reaction |
| 124812914 | 12481291 | 4 | Juvenile idiopathic arthritis |
| 124812914 | 12481291 | 5 | Dermatitis atopic |
| 124812914 | 12481291 | 6 | Nonspecific reaction |
| 124812914 | 12481291 | 7 | Dermatitis atopic |
| 124812914 | 12481291 | 8 | Dermatitis atopic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124812914 | 12481291 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124812914 | 12481291 | Cellulitis | |
| 124812914 | 12481291 | Juvenile idiopathic arthritis | |
| 124812914 | 12481291 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124812914 | 12481291 | 1 | 2007 | 0 | ||
| 124812914 | 12481291 | 2 | 20140829 | 0 | ||
| 124812914 | 12481291 | 3 | 20141027 | 0 | ||
| 124812914 | 12481291 | 4 | 20130531 | 0 | ||
| 124812914 | 12481291 | 5 | 20100312 | 0 | ||
| 124812914 | 12481291 | 7 | 2014 | 0 | ||
| 124812914 | 12481291 | 8 | 2014 | 0 |